Effects of anti-lymphocytes and anti-thymocytes globulin on human dendritic cells

International Immunopharmacology

Volumn 3, Issue 2, 2003, Pages 189-196

  Monti, Paolo ^a   Allavena, Paola ^b   Di Carlo, Valerio ^a   Piemonti, Lorenzo ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

Anti lymphocytes globulin; Anti thymocytes globulin; Dendritic cells

Indexed keywords

BETA1 INTEGRIN; CD11B ANTIGEN; CD32 ANTIGEN; CD4 ANTIGEN; CD61 ANTIGEN; CD86 ANTIGEN; COMPLEMENT; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; LUCIFER YELLOW; LYMPHOCYTE ANTIBODY; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T6 ANTIGEN; THYMOCYTE ANTIBODY;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CELL FUNCTION; CELL PROLIFERATION; CELL STIMULATION; COMPLEMENT ACTIVATION; COMPLEMENT DEPENDENT CYTOTOXICITY; COMPLEMENT INHIBITION; CONTROLLED STUDY; CYTOLYSIS; DENDRITIC CELL; ENDOCYTOSIS; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; MOLECULAR RECOGNITION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANTIBODY SPECIFICITY; ANTILYMPHOCYTE SERUM; CELLS, CULTURED; DENDRITIC CELLS; ENDOCYTOSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES;

EID: 0037315704     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5769(02)00253-9     Document Type: Article

References (35)

1. Woodruff M.F.A., Anderson N.A. Effect of lymphocyte depletion by thoracic duct fistula and administration of antilymphocyte serum on the survival of skin homograft in rat. Nature. 200:1963;702.
2. Thomas F., Thomas J., Flora R., Mendez-Picon G., Peace K., Lee H.M. Effect of antilymphocyte globulin potency on survival of cadaver renal transplant. Lancet. 2:1977;671.
3. Filo R.S., Smith E.J., Leapman S.B. Therapy of acute cadaveric renal allograft rejection with adjunctive antilymphocyte globulin. Transplantation. 30:1980;445.
4. Shield C.F. III, Cosimi A.B., Tolkoff-Rubin N., Rubin R.H., Herrin J., Russel P.S. Use of antithymocyte globulin for reversal of acute allograft rejection. Transplantation. 30:1980;445.
5. Dugan M.J., DeFor T.E., Steinbuch M., Filipovich A.H., Weisdorf D.J. ATG plus corticosteroid therapy for acute graft-versus-host disease: predictors of response and survival. Ann. Hematol. 75:1997;41.
6. Teramura M., Kobayashi S., Iwabe K., Yoshinaga K., Mizoguchi H. Mechanism of action of antithymocyte globulin in the treatment of aplastic anaemia: in vitro evidence for the presence of immunosuppressive mechanism. Br. J. Haematol. 96:1997;80.
7. Rebellato L.M., Gross U., Verbanac K.M., Thomas J.M. A comprehensive definition of the major antibody specificities in polyclonal rabbit antithymocyte globulin. Transplantation. 57:1994;685.
8. Bonnefoy-Berard N., Revillard J.P. Mechanisms of immunosuppression induced by antithymocyte globulins and OKT3. J. Heart Lung Transplant. 15:1996;435.
9. Merion R.M., Howell T., Bromberg J.S. Partial T-cell activation and anergy induction by polyclonal antithymocyte globulin. Transplantation. 65:1998;1481.
10. Steinman R.M. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9:1991;271.
11. Banchereau J., Steinman R.M. Dendritic cells and the control of immunity. Nature. 392:1998;245.
12. Hart D.N.J. Dendritic cells: unique leukocyte populations which control the primary immune response. Blood. 90:1997;3245.
13. Caux C., Liu Y.J., Banchereau J. Recent advances in the study of dendritic cells and follicular dendritic cells. Immunol. Today. 16:1995;2.
14. Hart D.N.J., Fabre J.W. MHC antigens in rat kidney ureter and bladder: localisation with monoclonal antibodies and demonstration of Ia positive dendritic cells. Transplantation. 31:1981;318.
15. Hart D.N.J., Fuggle S.V., Williams K.A., Fabre J.W., Ting A., Morris P.J. Localization of HLA-ABC and DR antigens in human kidney. Transplantation. 31:1981;428.
16. Lechler R.I., Batchelor J.R. Restoration of immunogenicity to passenger cell depleted kidney allografts by addition of donor strain dendritic cells. J. Exp. Med. 155:1982;31.
17. Larsen C.P., Morris P.J., Austyn J.M. Migration of dendritic cell leukocytes from cardiac allografts into host spleens, a novel pathway for initiation of rejection. J. Exp. Med. 171:1990;307.
18. Austyn J.M., Larsen C.P. Migration patterns of dendritic leukocytes. Implication for transplantation. Transplantation. 49:1990;1.
19. McKenzie J.L., Beard M.E.J., Hart D.N.J. Depletion of donor kidney dendritic cells prolongs graft survival. Transplant. Proc. 16:1984;948.
20. McKenzie J.L., Beard M.E.J., Hart D.N.J. The effect of donor pre-treatment on interstitial dendritic cell content and rat cardiac allograft survival. Transplantation. 38:1984;371.
21. Vitale M. NK function in flow cytometry. Cossarizza A. Advanced methodologies in flow cytometry. vol. 139:1997;139-145 Università degli Studi di Modena, Modena.
22. Gruessner R.W. Antibody induction therapy in pancreas transplantation. Transplant. Proc. 30:1998;1556.
23. Shield C.F., Edwards E.B., Davies D.B., Daily O.P. Antilymphocyte induction therapy in cadaver renal transplantation: a retrospective, multicenter united network for organ sharing study. Transplantation. 63:1997;1257.
24. Schulak J., May E., Post A., Fasola C., Mulligan D., Sterling R. Reduction of early rejection in adult liver transplantation with ATG induction therapy. Transplant. Proc. 29:1997;555.
25. Grant S.C.D., Lamb W.R., Yonan N., Hutchinson I.V., Brenchley P.E.C. Antithymocyte globulin preparations after heart transplantation. Transplantation. 60:1995;684.
26. Bourdage J.S., Hamlin D.M. Comparative polyclonal antithymocyte globulin and antilymphocyte/antilymphoblast globulin anti-CD antigen analysis by flow cytometry. Transplantation. 59:1995;1194.
27. Greco B., Bielory L., Stephany D. Antilymphocyte globulin reacts with many normal human cell types. Blood. 62:1983;1047.
28. Raefsky E.L., Gascon P., Gratwohl A., Speck B., Young N.S. Biological and immunological characterization of ALG and ATG. Blood. 68:1986;172.
29. Bonnefoy-Berard N., Vincent C., Revillard J.-P. Antibodies against functional leukocyte surface molecules in polyclonal antilymphocyte and antithymocyte globulins. Transplantation. 51:1991;669.
30. Steptoe R.J., Thomson A.W. Dendritic cells and tolerance induction. Clin. Exp. Immunol. 105:1996;397.
31. Lanzavecchia A. Receptor-mediated antigen uptake and its effect on antigen presentation to class II-restricted T lymphocytes. Annu. Rev. Immunol. 8:1990;773.
32. Sallusto F., Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down regulated by tumor necrosis factor α J. Exp. Med. 179:1994;1109.
33. Sallusto F., Cella M., Danieli C., Lanzavecchia A. Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: down regulation by cytokines and bacterial products. J. Exp. Med. 182:1995;389.
34. Reise Sousa C., Stahl P.D., Austyn J.M. Phagocytosis of antigens by Langerhans cells in vitro. J. Exp. Med. 178:1993;509.
35. Bonnefoy-Berard N., Verrier B., Vincent C., Revillard J.P. Inhibition of CD 25 (IL-2Ra) expression and T cell proliferation by polyclonal anti-thymocyte globulins. Immunology. 77:1992;61.